Change search criteria ↓

Search results

40 projects found matching your search criteria:

  1. 1. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 19, Panel: NZ7

  2. 2. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno…

    Principal investigator: Anna Karolina Pogorzelska

    Narodowy Instytut Leków

    Call: PRELUDIUM 20, Panel: NZ7

  3. 3. System engineering approach to modeling, analysis and prediction of outcome of combined anticancer therapies

    Principal investigator: prof. Andrzej Świerniak

    Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

    Call: OPUS 11, Panel: ST7

  4. 4. Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat…

    Principal investigator: dr hab. Kinga Sałat

    Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 9, Panel: NZ7

  5. 5. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer …

    Principal investigator: dr Anna Kawiak

    Uniwersytet Gdański

    Call: OPUS 2, Panel: NZ7

  6. 6. Hybrid Nanocomposites Based on Gold Nanoparticles as Promising Photoactive Materials for Combined Photothermal/Photodyna…

    Principal investigator: dr Paulina Błaszkiewicz

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

    Call: SONATINA 7, Panel: ST4

  7. 7. Synergistic enhancement of reactive oxygen species generation via combination of heavy atom effect with donor-acceptor a…

    Principal investigator: Karolina Anna Urbanowicz

    Politechnika Warszawska

    Call: PRELUDIUM 24, Panel: ST5

  8. 8. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud…

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ7

  9. 9. Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEb…

    Principal investigator: prof. Zuzanna - Drulis-Kawa

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: JPIAMR ACTION Call 2022, Panel: NZ6

  10. 10. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

    Principal investigator: dr Monika Anna Musiał-Kulik

    Centrum Materiałów Polimerowych i Węglowych PAN

    Call: SONATA 17, Panel: NZ7

  11. 11. Biocompatible NaRExTM1-xF4 nanoparticles combining the functions of luminescent nanothermometers and nanoheaters for pho…

    Principal investigator: Kamila Regina Maciejewska

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

    Call: PRELUDIUM 19, Panel: ST5

  12. 12. STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

    Principal investigator: dr hab. Ryszard Smolarczyk

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: OPUS 16, Panel: NZ5

  13. 13. Immersive virtual reality therapy combined with guided breathing exercises as a supportive intervention for reducing dep…

    Principal investigator: Magdalena Anna Nowak

    Politechnika Opolska

    Call: PRELUDIUM 24, Panel: NZ7

  14. 14. Nature-inspired conductive and bioadhesive kirigami-based nanoarchitectured cardiac patch for combined chemo- and stem c…

    Principal investigator: dr hab. Filippo Pierini

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

    Call: OPUS 26, Panel: ST5

  15. 15. "One step to game changer": combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes…

    Principal investigator: dr Barbara Ewa Pucelik

    Sieć Badawcza ŁUKASIEWICZ - Krakowski Instytut Technologiczny

    Call: SONATA 19, Panel: NZ7

  16. 16. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st…

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  17. 17. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 21, Panel: NZ7

  18. 18. Genetically modified dendritic cells as a component of combined therapy immunomodulating the tumor microenvironment

    Principal investigator: dr hab. Elżbieta Pajtasz-Piasecka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 14, Panel: NZ6

  19. 19. Co-delivery drug systems based on ionic graft polymers carrying pharmaceutical anions with antibacterial activities for …

    Principal investigator: prof. Dorota Neugebauer

    Politechnika Śląska, Wydział Chemiczny

    Call: OPUS 14, Panel: ST5

  20. 20. New, multifunctional nanoparticles for combined photothermal and gene silencing cancer therapy

    Principal investigator: prof. Stefan Jurga

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne

    Call: OPUS 11, Panel: ST8

  21. 21. Combined stem cell-based and gene therapy as a novel strategy to protect photoreceptors - evaluation of renewal mechanis…

    Principal investigator: prof. Bogusław Bronisław Machaliński

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim

    Call: OPUS 4, Panel: NZ5

  22. 22. Potential neuroprotective properties of therapy combining hyperbaric oxygen or hypobaric hypoxia postconditioning with m…

    Principal investigator: Marcin Gamdzyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 4, Panel: NZ4

  23. 23. Impact of combined therapy of non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors on oxida…

    Principal investigator: dr hab. Piotr Gałecki

    Uniwersytet Medyczny w Łodzi, Wydział Wojskowo-Lekarski; Klinika Psychiatrii Dorosłych

    Call: OPUS 3, Panel: NZ5

  24. 24. Combined targeted therapy with the use of PPAR receptor ligands or statins and cytostatics aimed at molecular mechanisms…

    Principal investigator: dr Wojciech Stanisław Placha

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: SONATA 1, Panel: NZ4

  25. 25. Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils…

    Principal investigator: Aleksandra Budzyńska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 1, Panel: NZ6

  26. 26. Phage-Antimicrobial combination Strategies for management of multidrug-resistant E. coli and K. pneumoniae

    Principal investigator: prof. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: JPIAMR ACTION Call 2024, Panel: NZ7

  27. 27. Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1…

    Principal investigator: Aneta Sylwia Nieznańska

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ5

  28. 28. New amide derivatives of cinnamic acid as a carbonyl reductase inhibitors, which modulate the activity of doxorubicin - …

    Principal investigator: dr Paulina Koczurkiewicz-Adamczyk

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 11, Panel: NZ7

  29. 29. Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

    Principal investigator: dr hab. Alicja Elżbieta Chrzanowska

    Warszawski Uniwersytet Medyczny

    Call: OPUS 20, Panel: NZ7

  30. 30. The combination of radiotherapy with imiquimod and sunitinib as a new therapeutic strategy overcoming some of the tumor …

    Principal investigator: dr Magdalena Jarosz-Biej

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: SONATA 14, Panel: NZ5

  31. 31. Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

    Principal investigator: dr Małgorzata Firczuk

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 11, Panel: NZ7

  32. 32. Combined induction of cell death of canine leukemia and lymphoma.

    Principal investigator: dr hab. Andrzej Marek Rapak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 2, Panel: NZ5

  33. 33. Anticancer activity of the thiosemicarbazone derivatives

    Principal investigator: dr Anna Dominika Mrozek-Wilczkiewicz

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

    Call: SONATA 7, Panel: NZ7

  34. 34. Natural and synthetic isothiocyanates as a compounds with potential anticancer activity

    Principal investigator: Mateusz Psurski

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 1, Panel: NZ4

  35. 35. Unlocking nature's potential - exploring the ability of newly isolated from the environment bacteriophage and its enzyme…

    Principal investigator: Aleksandra Łukasiak

    Uniwersytet Gdański, Wydział Biologii

    Call: PRELUDIUM 22, Panel: NZ9

  36. 36. Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

    Principal investigator: dr Anna Woziwodzka

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: SONATA 11, Panel: NZ7

  37. 37. Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

    Principal investigator: dr Łukasz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA 11, Panel: NZ7

  38. 38. The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

    Principal investigator: Alicja Patrycja Pawlak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 9, Panel: NZ3

  39. 39. The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance…

    Principal investigator: dr Magdalena Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 3, Panel: NZ5

  40. 40. Phytoecdysteroids as a potential drugs inhibiting Toxoplasma gondii invasion

    Principal investigator: dr Katarzyna Monika Dzitko

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 1, Panel: NZ6

Graphic design and implementation: Jakub Piotrowski